- Definition: The One compartment open model treats the
body as one homogeneous volume in which mixing is
instantaneous. Input and output are from this one volume.
- [full] [icon] Figure: Diagram
of 1-COM with terms
- Assumptions:
- Body is one homogeneous compartment -- Problems?
Practicalities?
- Instantaneous mixing -- Must be instantaneous
"relative to the time scale of
measurement"
- Applicable only to first order processes
- [full] [icon] Figure: Plot of 1-COM
plus formula
- [do plot][how?] Plot 1-COM
formula and enter various values for A and Ke (actually, elimination half-life) using
a spreadsheet. (NOTE: You must have
Microsoft Excel installed on your machine and your browser
must be appropriately setup for
this to work)
One compartment open
model
Cp(t) = A * e(-Ke * t)
(mg/L = mg/L * e(frcn/hr * hr))
Using a calculator
|
- Cp(t) = concentration in plasma
at defined time interval after the time of known
concentration corresponding to "A"
- A = Known (or estimated)
concentration.
Can be known by actual measurement or estimated
by using Cp(0) = (F * D)/Vd. Could be thought of
as an "anchor" point.
- e = base of natural logarithms
- Ke = elimination rate constant
(-Ke is the slope of the line)
- t = selected time after time of anchor
concentration.
|
- Get the semi-log plot you made for miraclemycin in the 70 kg patient in the
volume of distribution discussion.
- Identify the various parts of the 1-COM formula on the
graph.
- Focus
on the "A" term
- At what time after a drug is given can one make
the best "guestimate" of the value of
"A" if the drug is given IV?
- What does the term Cp(0)
mean?
- How could one estimate Cp(0) given values
for the following and assuming instantaneous
absorption and distribution? Vd, Dose, F
- Understanding the "A" is a
"scaling" factor and that it can be any
place on the time axis where one has a
reasonable ability to know its value will give
one a big boost in understanding simple clinical
pharmacokinetics.
- [do_plot] Exercises
involving "A" -- Enter different
numbers for Dose, F, and Vd into spreadsheet to
see the effect on plot of 1-COM. (NOTE:Your browser
must be appropriately setup for this to work)
- Does "A" have to be at the
zero-time point on the graph? What if one knows
from measuring drug concentration, the value at 5
hours? Could one estimate the concentration at,
e.g., 10 hours after a dose, given a measured
5-hour concentration and a Ke?
The plasma concentration of drugs given by infusion at
constant rate or by repeated dosing at a constant rate will rise
until the concentration high enough that elimination is equal to
input. This is termed "accumulation".
Retrieve or remake graph of Miraclemycin from data in the
lecture on volume of distribution (Vd). [70 Kg data] The data to make
the graph are repeated here.
- 70 kg patient given dose of 2,800 mg of
miraclemycin
- Plasma drug concentrations --
Times (hrs) |
2 |
4 |
6 |
8 |
Conc (mg/L) |
10 |
5 |
2.5 |
1.25 |
|
- What is the concentration at 8 hr after administering the
drug?
- What was the "zero-time" concentration in that
graph?
- Assuming IV administration and instantaneous
distribution, what would the concentration be if an
identical dose (2800 mg) were given at 4 hours? (Note:
rise in concentration with each dose is 20 mg/L)
- What is the new peak?
- What is the concentration 4 hr after 2nd dose?
- Do this exercise for at least 2 more doses.
- Does the curve keep rising at the same rate?
- Concentrations in this scenario are:
Dose |
First |
Second |
Third |
Fourth |
Peak |
20 |
25 |
26.25 |
26.56 |
Trough |
5 |
6.25 |
6.56 |
6.64 |
Concentrations are mg/L |
Calculation
- Calculation of accumulation factor for repeated doses
RA
= 1 / [1 - e(-Ke * T)] |
RA = Accumulation
factor (a ratio)
Ke = elimination rate constant (/hr)
T = dose interval (hr) |
- When T < 5 half-lives accumulation will occur
- Examples of relationship between T & Ke on
accumulation
Accumulation Factor: Effect of
Half-life and Dose Interval |
Rates |
Accumulation Factor |
half-life
(h) |
Ke
(frcn/h) |
Dose Interval (h) |
1 |
2 |
12 |
24 |
2 |
0.3465 |
3.4 |
2.0 |
1.0 |
1.0 |
50 |
0.0139 |
72.71 |
36.6 |
6.5 |
3.5 |
- Note from the table that given equal dose intervals,
e.g., 24 h, the drug with the longer half-life will
accumulate more. See multiplier 1.0 versus 3.5.
- Changes in half-life: It should be apparent from
this that changes in half-life during therapy can
have tremendous effects on steady state drug
concentrations. Such changes can occur during
disease
- Interindividual variation in half-life: . There
is also a large interindividual variation in
elimination half-life so accumulation may be more
pronounced in one patient than another.
- Examples of some actual concentrations
Peak Concentration at SS vs Initial Peak |
half-life
(h) |
Initial Peak |
Dose Interval (h) |
1 |
2 |
12 |
24 |
(mg/L) |
(mg/L) |
(mg/L) |
(mg/L |
mg/L |
2 |
20.0 |
68.3 |
40.0 |
20.3 |
20.0 |
50 |
20.0 |
1453.0 |
731.5 |
130.5 |
70.7 |
On repeated "bolus" administration of drug, the
concentration in the plasma oscillates between the peak
and the trough. The importance of the degree of oscillation is
drug dependent and depends on the dose, dose interval, and
elimination half-life.
- Oscillation can be viewed as a (an) --
- ratio -- determined by Dose interval and
half-life
- absolute amount in mg/L (determined by dose
interval, half-life, and (F* dose/Vd))
- Ratio of peak to trough depends on --
- Dose interval
- Elimination half-life
- [Excel] [how?] Use spreadsheet to
see influence of varying T and half-life on the
ratio of peak to trough
-
Oscillation
ratio = 1/e-(Ke* T) |
Ke = elimination rate
constant
T = dose interval |
- Absolute oscillation also includes factor: F*D/Vd
- Ratio: Peak to trough
- At T = half-life, Ratio is 2!, i.e., Peak is
twice the trough
- At T<half-life, Ratio is <2
- At T>half-life, Ratio is >2
- As T increases, Ratio approaches infinity
- As T decreases, Ratio approaches infinitesimal
- Importance of degree of oscillation
- Importance is drug dependent
-
- The height and shape of the peak on a plot of drug
concentration versus time depends on
- Ka = absorption rate
- Ke = elimination rate
- F*D/Vd
- IV administration gives the sharpest peaks and is
the standard for Ka>>Ke.
Ka >> Ke means absorption is much faster
than elimination so nearly all of the drug is
absorbed before a significant amount is
eliminated.
- PO (per os) and other routes of adminstration and
use of slowly absorbing dose forms may cause
peaks to be much flatter.
- Formulae used below to calculate Peak and Trough
concentrations at steady state and with repeated
doses, assume Ka>>Ke. When this condition
is NOT true, actual peaks will be less and actual
troughs will be higher than predicted by the
formulae.
- [EXCEL] [how?]
Try different values of absorption half-life given a
constant elimination half-life to see the influence of
varying absorption rate on the shape of the curve. Note
the ordinate is in terms of "multiples of the
elimination half-life."
To calculate Peak concentration at steady
state (Css(max))
Css(max)
= (F*D/Vd) * {1 / [1 - e-(Ke * T)]}
mg/L = (frcn * mg/L) * {1 / [1 - e-(hr-1
* hr)]} |
Css(max) = Peak
concentration at steady state assuming Ka >> Ke
F = bioavailability
D = dose
Vd = volume of distribution
Ke = elimination rate constant
T = dose interval |
- Use of (F*D/Vd) to estimate peak concentration of the first
dose
- Qualifier that Ka >> Ke, i.e., absorption rate must
be much faster than elimination rate. This is true for IV
injections an some intramuscular injections.
- When Ka >> Ke is NOT TRUE, the true peak will be
less than that estimated by this formula. This is a
safety factor in many situations where we use this
formula to estimate the peak concentration.
To calculate Trough concentration at steady
state (Css(min))
Css(min)
= Css(max) * e-(Ke * T) |
Css(min)= Trough concentration at steady state (mg/L)
Css(max) = Peak
concentration at steady state as calculated using
appropriate formula (mg/L)
Ke = Elimination rate constant (hr-1)
T = Dose interval (hr) |
- Note the obvious similarity of this formula to the
standard 1-COM formula!
Send suggestions /
questions
Last modified: 04 Sep 1996 14:03 glc